يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"La Police, David"', وقت الاستعلام: 1.16s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), University of Glasgow, National Heart Centre Singapore (NHCS), University Medical Center Groningen Groningen (UMCG), Berlin-Brandenburg Center for Regenerative Therapies Berlin, Germany, Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Brigham and Women's Hospital Boston, Janssen Research & Development, University of Michigan Ann Arbor, University of Michigan System, Department of Medicine Univ California San Diego (MED - UC San Diego), School of Medicine Univ California San Diego (UC San Diego), University of California San Diego (UC San Diego), University of California (UC)-University of California (UC)-University of California San Diego (UC San Diego), University of California (UC)-University of California (UC), The COMMANDER-HF trial was supported by Janssen Research and Development

    المصدر: ISSN: 1861-0684.

  2. 2
    دورية أكاديمية

    المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), University of Glasgow, National Heart Centre Singapore (NHCS), Duke-National University of Singapore Graduate Medical School, University Medical Center Groningen Groningen (UMCG), Janssen Research & Development, Berlin-Brandenburg Center for Regenerative Therapies, Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Brigham and Women's Hospital Boston, Service d'Hématologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), University of California San Diego (UC San Diego), University of California (UC), Funding Support and Author Disclosures The COMMANDER-HF trial was supported by Janssen Research and Development. Drs. Ferreira, Rossignol, and Zannad are supported by Reseau Hospitalo-Universitaire Fight-HF, a public grant overseen by the French National Research Agency as part of the second “Investissements d’Avenir” program (reference: ANR-15-RHUS-0004) and by the French Investments for the Future Program project “Lorraine Université d’Excellence” (reference: ANR-15-IDEX-04-LUE). The biobanking for rivaroxaban dosages is managed by Biological Resource Center Lorrain BB-0033-00035. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015)

    المصدر: ISSN: 2213-1779.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33549557; hal-03166650; https://hal.univ-lorraine.fr/hal-03166650Test; https://hal.univ-lorraine.fr/hal-03166650/documentTest; https://hal.univ-lorraine.fr/hal-03166650/file/S2213177920307022.pdfTest; PII: S2213-1779(20)30702-2; PUBMED: 33549557

  3. 3
    دورية أكاديمية

    المصدر: Ferreira , J P , Lam , C S P , Anker , S D , Mehra , M R , van Veldhuisen , D J , Byra , W M , La Police , D A , Cleland , J G F , Greenberg , B & Zannad , F 2021 , ' PlasmaD-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm : an analysis from theCOMMANDER-HFtrial ' , European Journal of Heart Failure , vol. 23 , no. 4 , pp. 648-656 . https://doi.org/10.1002/ejhf.2003Test

    وصف الملف: application/pdf

  4. 4
    دورية أكاديمية

    المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), National Heart Centre Singapore (NHCS), University Medical Center Groningen Groningen (UMCG), Berlin-Brandenburg Center for Regenerative Therapies Berlin, Germany, Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Brigham & Women’s Hospital Boston (BWH), Harvard Medical School Boston (HMS), Janssen Research & Development, Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow and National Heart & Lung Institute, Cardiology Division, Department of Medicine, University of California, San Diego, The COMMANDER-HF trial was supported by Janssen Research and Development

    المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-03009383Test ; European Journal of Heart Failure, 2020, ⟨10.1002/ejhf.2003⟩.

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    مؤتمر
  10. 10
    دورية